Fig. 2: Impact of the interplay between cytogenetic risk and mutational status on prognosis. | Blood Cancer Journal

Fig. 2: Impact of the interplay between cytogenetic risk and mutational status on prognosis.

From: Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification

Fig. 2: Impact of the interplay between cytogenetic risk and mutational status on prognosis.

Survival outcomes for a LFS and b OS across subgroups stratified by mutational status and IPSS-R cytogenetic risk categories. Subgroups include: GK (very good/good), IK (intermediate), and PK (poor/very poor) karyotypes, with or without concomitant gene mutations.

Back to article page